An interventional study of Virtual reality (VR) therapy in Delirium in the Intensive Care Unit, Sleep Quality in Adult ICU Patients and Agitation Associated With Critical Illness, sponsored by Milton S. Hershey Medical Center. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Milton S. Hershey Medical Center · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Pain by Milton S. Hershey Medical Center — none open to participants now, 1 under way, none of them phase 3. Pain · Milton S. Hershey Medical Center.
Among the 12 studies in Pain by Milton S. Hershey Medical Center, this one is the only one that started in 2026, is one of 6 with no phase, and was the 12th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →None of the 12 studies in Pain by Milton S. Hershey Medical Center is open now. The open studies under Pain, anywhere →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 1 · Phase 3 2
First in 2003; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 56 across the 9 interventional studies, 30 across the 3 observational. Of the 9 that completed or were terminated, 3 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
Milton S. Hershey Medical Center is the lead sponsor of 493 studies on the registry; 60 are open to participants now.
Of its 58 completed or terminated interventional studies of FDA-regulated products, 46 (79%) have results posted.
1 of the studies in Pain by Milton S. Hershey Medical Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06141720Milton S. Hershey Medical CenterFeasibility of a Mindfulness Intervention for Endometriosis Surgery | 2027-01-30 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Pain by Milton S. Hershey Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and/or the specific VR software used for the research
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Critically ill patients
Behavioral: Virtual reality (VR) therapy
VR sessions will use a commercially available headset with non-interactive, immersive content displaying calming nature-based content (e.g., ocean/beach scenes, forests, mountains) delivered through a commercially available VR application
Feasibility of Intervention Measure (FIM)
Time frame: From time of enrollment to end of intervention at 3 days
Acceptability of Intervention Measure (AIM)
Time frame: From time of enrollment to end of intervention at 3 days
Intervention Appropriateness Measure (IAM)
Time frame: From time of enrollment to end of intervention at 3 days
Ran from Jun 2026 to primary completion in Sep 2026, 2 months.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 2 months is below that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Milton S. Hershey Medical Center →